Welcome to our dedicated page for Fosun Internatio news (Ticker: FOSUY), a resource for investors and traders seeking the latest updates and insights on Fosun Internatio stock.
News about Fosun International Limited (FOSUY) covers a broad range of topics reflecting its activities as a global innovation-driven consumer group. Company announcements and media releases describe developments across pharmaceuticals and healthcare, cultural tourism and consumption, financial services, and insurance, as well as updates on its innovation and globalization strategy.
Investors and observers can find news on Fosun’s pharmaceutical and healthcare initiatives, including progress in innovative drugs, medical devices, and healthcare services under entities such as Fosun Pharma and Henlius. Releases highlight clinical and regulatory milestones, new therapeutic indications, and the use of artificial intelligence in areas such as drug development decision-making and clinical trial prediction.
Coverage also includes cultural tourism and consumption news, such as performance and expansion of Club Med resorts under Fosun Tourism Group, cultural events, and consumer-focused projects. In financial services and insurance, news items discuss developments at Fosun Insurance Portugal (Fidelidade), asset servicing activities in Europe, and strategic portfolio adjustments, including asset sales and retained businesses.
Another important theme in Fosun-related news is ESG and sustainability. Articles describe its ESG ratings, inclusion in sustainability indices and yearbooks, climate disclosure practices, and social responsibility programs such as the Rural Doctors Program and contributions to global malaria treatment. Governance and award recognitions, including honors from organizations like Corporate Governance Asia, also feature prominently.
For those following FOSUY, this news stream provides insight into how Fosun advances its stated strategy of "Innovation + Globalization", how its core subsidiaries perform, and how it integrates ESG considerations into its operations. Regularly reviewing these updates can help readers understand the group’s evolving business focus and corporate priorities.
On June 18, 2024, over 40 diplomats, including ambassadors and consuls general from 26 countries, visited Fosun in Shanghai. The delegation toured the Grand Yuyuan, experiencing both the cultural heritage of old Shanghai and Fosun's global business achievements. Organized by China's Ministry of Foreign Affairs and Shanghai's Foreign Affairs Office, the event aimed to foster international business cooperation.
Fosun, a global innovation-driven consumer group, operates in over 35 countries across sectors like pharmaceuticals, culture & tourism, and finance. Diplomats showed interest in further business collaborations. Highlights included Fosun's achievements in pharmaceuticals, such as the global approval of their drugs HANSIZHUANG, HANQUYOU, and HANLIKANG, and their significant revenue from international markets, accounting for 45% of total revenue in 2023.
Fosun also showcased the Yuyuan Garden Lantern Festival and ongoing Grand Yuyuan project, aiming to develop this area into a major cultural and commercial hub. Diplomats expressed keen interest in participating in future cultural events and business opportunities with Fosun.
Finloop, an independently incubated digital wealth management platform by Fosun Wealth, has entered strategic agreements with several leading fintech companies, including China Asset Management and Ping An of China Asset Management. These agreements aim to boost digital transformation in wealth management and cater to personalized client needs. Finloop's assets under management are projected to exceed HK$10 billion this year, aiming for hundreds of billions in the next three years. Fosun's long-term investment in technology innovation has entered a fruitful phase, with Finloop showcasing industry-leading R&D capabilities. Fosun International Securities has also obtained a virtual asset dealing service license from Hong Kong's SFC, broadening its investment services to include virtual assets. The expected interest rate cuts in the latter half of the year could further enhance the investment climate.
On May 31, 2024, Fosun International was honored with four prestigious awards by Corporate Governance Asia. Executive Directors and Co-CEOs, Chen Qiyu and Xu Xiaoliang, received the Asia's Best CEO Award. The company also secured the Sustainable Asia Award and Best Corporate Communications Award. These accolades recognize Fosun's excellence in financial performance, corporate governance, ESG efforts, and investor relations despite a challenging macroeconomic environment. Fosun's strategic focus on core businesses and operational resilience helped achieve steady growth, demonstrated by their solid ESG performance, including an MSCI ESG rating of AA for three consecutive years.
At the 4th BEYOND International Technology Innovation Expo 2024, Fosun International Chairman Guo Guangchang announced the company's long-term strategy focused on innovation and globalization. Aiming for stable revenue and profit growth, Fosun seeks to enhance its global operations and leverage international resources. Guangchang highlights the potential to cure cancer through Fosun's CAR-T cell therapy, which shows promising results. The company remains committed to philanthropic efforts, particularly in rural healthcare. Fosun's presence at the expo underscores its achievements in healthcare and technology innovation.
The 6th annual 515 Fosun Family Day kicked off on May 15, 2024, bringing together thousands of families across various commercial districts in China to celebrate the 'Fosun lifestyle'.
The event, themed around creating happy family experiences, featured numerous activities and promotions in cities like Shanghai, Tianjin, Chongqing, and Shenzhen from May 11-20. Highlights included painting sessions, interactive experiences, fitness classes, and exclusive product discounts.
Fosun aims to deepen its connection with consumers through these activities, aligning with Shanghai's Double Five Shopping Festival. The company organized over 600 activities in more than 10 commercial districts to boost offline consumption.
Member benefits were enhanced through partnerships with Alipay and OCJ.COM.CN, offering significant discounts and special promotions.
Fosun's efforts reflect its long-term focus on the family consumption industry, aiming to create happier lives for families worldwide.
On May 13, 2024, Fosun International's Chairman, Guo Guangchang, attended the Choose France Summit in Paris. The summit, hosted by the French government, aims to highlight France's investment appeal. Guo Guangchang engaged with French officials and business leaders from prominent companies like BNP Paribas and AXA. Fosun's extensive business presence in France includes sectors like tourism, fashion, pharmaceuticals, and food, with annual revenue exceeding 2 billion euros and over 10,000 local employees. Fosun has significantly contributed to Franco-Chinese business and cultural exchanges since entering the French market in 2010. The company owns renowned brands such as Club Med and Lanvin. Fosun also promoted the Yuyuan Lantern Festival in Paris last year, attracting nearly 200,000 visitors. The event marks Fosun's third participation in the summit, emphasizing its commitment to fostering further Franco-Chinese cooperation.
On May 13, 2024, Fosun International (HKEX: 00656) was included in the 2024 Fortune China ESG Impact List, highlighting its leadership in environmental, social, and governance (ESG) practices. Fosun has shown commitment to sustainable development, despite challenging macroeconomic conditions. The company received an MSCI ESG rating of AA for three consecutive years and improved its HSI ESG rating to AA-. It made significant strides in healthcare innovation, with new approvals for anticancer and antimalarial drugs. Fosun's achievements also include inclusion in prominent sustainability indices and recognition as an 'Industry Mover' by S&P Global.
Fosun International successfully completed the refinancing of its USD804 million loan, obtaining a new syndicate loan of USD597 million and repaying the remaining through its own funds. The collaboration with banking partners resulted in the largest syndicated loan for a Chinese privately-owned enterprise this year, showcasing Fosun's strong liquidity and support from domestic and foreign banks.
Fosun has diversified financing channels, solid financing capabilities, and prudent financial policies. The company aims to optimize its debt structure, strengthen liquidity management, and focus on core business strategies for steady development.
Summary not available.
Summary not available.